Delivering Predictable Timelines for Improved Vaccines Outcomes

whitePaper | March 23, 2023

DCTs can take a variety of forms depending on patients’ needs, study protocol, drug company preferences, or regulatory requirements. Trials may be remote and decentralised from start to finish with no physical contact between participants and investigators or they may rely on hybrid designs that incorporate only certain elements of decentralisatio

whitePaper | November 8, 2022

This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings.

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

whitePaper | January 17, 2020

Value-based reimbursement (VBR) models are becoming more common. Success under these models depends on showing positive improvement in key metrics, but providers often struggle to accurately report the quality of care provided. A next-generation revenue cycle that combines clinically aware artificial intelligence (AI) with an unmatched foundation of evidence-based medical research and knowledge provides the transparency necessary to both accurately report care quality and directly influence the patient satisfaction quality metric. This paper reviews how a well-tuned revenue cycle can help hospitals succeed with value-based contracts, earning appropriate incentives and avoiding penalties.

whitePaper | January 2, 2023

a buying guide to help you choose a healthcare-contextualized CRMsolution that connects consumer experiences and clinical care journeys tohelp you find, guide, and keep patients for life

whitePaper | February 15, 2022

Every provider wants to innovate to drive transformation that helps reduce variability, improve efficiency, and support optimal patient care. The question is, how disruptive, in a positive sense, is your innovation? Most innovations in provider organizations are, in truth, iterative tweaks. While tweaks are the cornerstone of continuous improvement lifecycles, iteration isn’t the kind of transformation needed in healthcare. Real innovation creates a disruptive solution that fundamentally changes how people and processes work together, for the better.